Registro:

Referencias:

• Strand, V., Talal, N., Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy) (1980) Bull. Rheum. Dis., 92, pp. 212-226
• Jacobsson, L.T.H., Manthorpe, R., Epidemiology of Sjögren's syndrome (1995) Rheumatol. Eur., 24, pp. 46-47
• Fox, R.I., Michelson, P., Approaches to the treatment of Sjögren's syndrome (2000) J. Rheumatol., 27, pp. 15-21
• Manthorpe, R., Asmussen, K., Oxholm, P., Primary Sjögren's syndrome criteria, clinical features and disease activity (1997) J. Rheumatol., 24 (SUPPL. 50), pp. 8-11
• Fox, R.I., Maruyama, T., Pathogenesis and treatment of Sjögren's syndrome (1997) Curr. Opin. Rheumatol., 9, pp. 393-399
• Bacman, S., Sterin-Borda, L., Camusso, J.J., Arana, R., Hubscher, O., Borda, E., Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome (1996) Clin. Exp. Immunol., 104, pp. 454-459
• Bacman, S., Perez Leiros, C., Sterin-Borda, L., Hubscher, O., Arana, R., Borda, E., Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome (1998) Invest. Opthalmol. Vis. Sci., 39, pp. 151-156
• Perez Leiros, C., Sterin-Borda, L., Hubscher, O., Arana, R., Borda, E., Activation of nitric oxide signaling through muscarinic receptors in submandibular glands by primary Sjögren's syndrome antibodies (1999) Clin. Immunol., 90, pp. 190-195
• Miyagawa, J., Ultrastructural immunocytochemical submandibulitis in the non-obese diabetic (NOD) mouse (1986) Virchows Arch. (Cell. Pathol.), 51, pp. 215-225
• Humphreys-Beher, M.G., Hu, Y., Nakagawa, Y., Wang, P.L., Purushotham, K.R., Utilization of the NOD mouse as a model for the study of secondary Sjögren's syndrome (1994) Adv. Exp. Med. Biol., 350, pp. 631-637
• Yamano, S., Atkinson, J.C., Baum, B.J., Fox, P.C., Salivary gland cytokine expression in NOD and normal BALB/c mice (1999) Clin. Immunol., 92, pp. 265-275
• Yamamoto, H., Sims, N.E., Macauley, S.P., Nguyen, K.H.T., Nakagawa, Y., Humphreys-Beher, M.G., Alterations in the secretory response of non-obese diabetic (NOD) mice to muscarinic receptor stimulation (1996) Clin. Immunol. Immunopathol., 78, pp. 245-255
• Moncada, S., Palmer, R.M.J., Higgs, E.A., Nitric oxide physiology, pathophysiology and pharmacology (1991) Pharmacol. Rev., 43, pp. 109-142
• Nathan, C., Inducible nitric oxide synthase: What difference does it make? (1997) J. Clin. Invest., 100, pp. 2417-2423
• Edwards, A.V., Garrett, J.R., Nitric oxide-related vasodilator responses to sympathetic stimulation of the submandibular gland in the cat (1993) J. Physiol., 464, pp. 379-392
• Lomniczi, A., Suburo, A.M., Elverdin, J.C., Mastronardi, C.A., Diaz, S., Rettori, V., McCann, S.M., Role of nitric oxide in salivary secretion (1998) Neuroimmunomodulation, 5, pp. 226-233
• Lohinai, Z., Burghardt, B., Zelles, T., Varga, G., Nitric oxide modulates salivary amylase and fluid, but not epidermal growth factor secretion in conscious rats (1999) Life Sci., 64, pp. 953-963
• Nathan, C., Xie, Q.W., Regulation of biosynthesis of nitric oxide (1994) J. Biol. Chem., 269, pp. 13725-13728
• Förstermann, U., Boissel, J.P., Kleinert, H., Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOS I and NOS III) (1998) FASEB J., 12, pp. 773-790
• Perez Leiros, C., Goren, N., Sterin-Borda, L., Lustig, L., Borda, E.S., Alterations in cardiac muscarinic acetylcholine receptors in mice with autoimmune myocarditis and association with circulating muscarinic receptor-related autoantibodies (1994) Clin. Auton. Res., 4, pp. 249-255
• Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the Folin phenol reagent (1951) J. Biol. Chem., 193, pp. 265-275
• Bernfeld, P., Amylase, alpha and beta (1955) Methods Enzymol., 1, pp. 149-158
• Perez Leiros, C., Rosignoli, F., Genaro, A.M., Sales, M.E., Sterin-Borda, L., Borda, E.S., Differential activation of nitric oxide synthase through muscarinic acetylcholine receptors in rat salivary glands (2000) J. Auton. Nerv. Syst., 79, pp. 99-107
• Davel, L., Eiján, A.M., Sales, M.E., Español, A., D'Agostino, A., Diccardo, I., Lustig, E.S., Jasnis, M.A., Nitric oxide and prostaglandin E2 regulate the biological activity of tumor draining lymph nodes in a murine mammary adenocarcinoma (2000) Nitric Oxide Biol. Chem., , in press
• Murthy, K.S., Zhang, K.-M., Jin, J.G., Grider, J.R., Makhlouf, G.M., VIP-mediated G protein-coupled Ca2+ influx activates a constitutive NOS in dispersed gastric muscle cells (1993) Am. J. Physiol., 265, pp. G660-G671
• Kontinnen, Y.T., Platts, L.A.M., Tuominen, S., Eklund, K.K., Santavirta, N., Törnwall, J., Sorsa, T., Polak, J.M., Role of nitric oxide in Sjögren's syndrome (1997) Arthritis Rheum., 40, pp. 875-883
• Lohinai, Z., Szekely, A.D., Soos, L., Feher, E., Distribution of nitric oxide synthase containing elements in the feline submandibular gland (1995) Neurosci. Lett., 192, pp. 9-12
• Hu, Y., Nakagawa, Y., Purshotham, K., Humphreys-Beher, M.G., Functional changes in salivary glands of autoimmune disease-prone NOD mice (1992) Am. J. Physiol., 263, pp. E607-E614
• Robinson, C.P., Yamamoto, H., Peck, A.B., Humphreys-Beher, M.G., Genetically programmed development of salivary gland abnormalities in the NOD-scid mouse: A potential trigger for sialoadenitis of NOD mice (1996) Clin. Immunol. Immunopathol., 79, pp. 50-59
• Shaw, P., Sordat, B., Schibler, U., Developmental coordination of α amylase and PSP gene expression during mouse parotid gland differentiation is controlled posttranscriptionally (1986) Cell, 47, pp. 107-112
• Rosignoli, F., Pérez Leirós, C., Activation of nitric oxide synthase through muscarinic acetylcholine receptors in rat parotid (2000) Br. J. Pharmacol., 131, p. 55
• Said, S., VIP as a modulator of lung inflammation and airway constriction (1991) Am. Rev. Respir. Dis., 143, pp. 22-24
• Yamamoto, H., Ishibashi, K., Nakagawa, Y., Maeda, N., Zeng, T., Robinson, C.P., Oxford, G.E., Humphreys-Beher, M.G., Detection of alterations in the levels of neuropeptides and salivary gland responses in the non-obese diabetic mouse model for autoimmune sialoadenitis (1997) Scand. J. Immunol., 45, pp. 55-61
• Roitt, I.M., Brostoff, J., Male, D., Autoimmunity and autoimmune disease (1998) Immunology, pp. 367-380. , Mosby, London
• Hu, Y., Purushotham, K.R., Wang, P.L., Dawson, R., Humphreys-Beher, M.G., Down-regulation of β adrenergic receptors and signal transduction response in salivary glands of NOD mice (1994) Am. J. Physiol., 266, pp. G433-G443
• Nguyen, K.H.T., Brayer, J., Cha, S., Diggs, S., Yasunari, U., Hilal, G., Peck, A.B., Humphreys-Beher, M.G., Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice (2000) Arthritis Rheum., 43, pp. 2297-2306
• Goin, J.C., Perez Leiros, C., Borda, E., Sterin-Borda, L., Interaction of human chagasic IgG with the second extracellular loop of the human Heart muscarinic acetylcholine receptor: Functional and pathological implications (1997) FASEB J., 10, pp. 77-83
• Perez Leiros, C., Sterin-Borda, L., Borda, E., β-adrenergic cardiac antibody in autoimmune myocarditis (1989) Autoimmunity, 2, pp. 223-234
• Bijlsma, J.W.J., Cutolo, M., Masi, A.T., Chikanza, I.C., The neuroendocrine immune basis of rheumatic diseases (1999) Immunol. Today, 20, pp. 298-301

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------